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Abstract
Objective
Patients with type 2 diabetes usually show reduced physical activity (PA) and increased
sedentary (SED)-time, though to a varying extent, especially for low-intensity PA (LPA), a
major determinant of daily energy expenditure that is not accurately captured by question-
naires. This study assessed the level and correlates of PA and SED-time in patients from
the Italian Diabetes and Exercise Study_2 (IDES_2).
Methods
Three-hundred physically inactive and sedentary patients with type 2 diabetes were enrolled
in the IDES_2 to be randomized to an intervention group, receiving theoretical and practical
exercise counseling, and a control group, receiving standard care. At baseline, LPA, moder-
ate-to-vigorous-intensity PA (MVPA), and SED-time were measured by accelerometer.
Physical fitness and cardiovascular risk factors and scores were also assessed.
Results
LPA was 3.93±1.35 hoursday-1, MVPA was 12.4±4.6 minday-1, and SED-time was 11.6
±1.2 hoursday-1, with a large range of values (0.89–7.11 hoursday-1, 0.6–21.0 minday-1,
and 9.14–15.28 hoursday-1, respectively). At bivariate analysis, LPA and MVPA correlated
with better cardiovascular risk profile and fitness parameters, whereas the opposite was
observed for SED-time. Likewise, values of LPA, MVPA, and SED-time falling in the best
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tertile were associated with optimal or acceptable levels of cardiovascular risk factors and
scores. At multivariate analysis, age, female gender, HbA1c, BMI or waist circumference,
and high-sensitivity C reactive protein (for LPA and SED-time only) were negatively associ-
ated with LPA and MPA and positively associated with SED-time in an independent manner.
Conclusions
Physically inactive and sedentary patients with type 2 diabetes from the IDES_2 show a low
level of PA, though values of LPA, MVPA, and SED-time vary largely. Furthermore, there is
a strong correlation of these measures with glycemic control, adiposity and inflammation,
thus suggesting that even small improvements in LPA, MVPA, and SED-time might be asso-
ciated with significant improvement in cardiovascular risk profile.
Trial registration
ClinicalTrials.gov NCT01600937
Introduction
Physical inactivity, i.e. an insufficient amount of physical activity (PA) according to current
guidelines, and sedentary behavior, i.e. a large amount of time spent in a sitting or reclining
posture, have become the major determinants of the epidemic of obesity and type 2 diabetes.
Recent data from the National Health and Nutrition Examination Survey (NHANES) indicate
that the dramatic rise in the prevalence of obesity and abdominal adiposity among US adults
from 1988 to 2010 was associated with an increased proportion of subjects reporting no lei-
sure-time PA, but not with changes in average caloric intake [1]. Another report from the
NHANES (1988–2008) shows that less than 50% of US adults achieve the recommended PA
level and ~30% of them engage in no PA at all, though projections to 2020 suggest some
improvement [2]. The prevalence of physical inactivity is even higher in individuals with type
2 diabetes or in those at highest risk for developing this condition. In fact, in the Medical
Expenditure Panel Survey, only 39% of adults with diabetes were physically active versus 58%
of those without diabetes and the proportion of active adults without diabetes declined as the
number of risk factors increased [3]. Physical inactivity is also a major predictor of all-cause
mortality in subjects with type 2 diabetes [4–6].
However, recent findings from individuals with type 2 diabetes indicate a significant associ-
ation between sedentary (SED)-time and metabolic risk, independently of several confound-
ers, including time spent in moderate-to-vigorous-intensity PA (MVPA). Indeed, MVPA was
not associated with clustered metabolic risk after accounting for SED-time [7, 8]. These reports
are consistent with previous studies showing a positive relationship between daily sitting time
or television viewing with all-cause and cardiovascular mortality [9, 10] as well as cardiovascu-
lar risk factors [11, 12]. Taken together, the above observations support the concept that physi-
cally inactivity and sedentary behavior influence health outcomes through distinct pathways
and highlight the need to target both conditions. In fact, the recommended amount of daily
MVPA (30 min) [13] represents less than 5% of the time spent awake. Thus, additional efforts
should be made to reduce sedentary behaviors during the rest of the day by promoting light-
intensity PA (LPA), which is a major determinant of total daily energy expenditure and may
be increased more easily than MVPA in patients with type 2 diabetes [14, 15]. A recent report
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from the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study showed that sitting-
reduction strategies targeting increased standing, stepping, or both, may benefit cardio-meta-
bolic health [16].
Although PA/exercise is now considered as a cornerstone of prevention and management
of type 2 diabetes [17, 18], it is difficult to put into action PA/exercise recommendations for a
number of barriers [19]. In particular, compliance is usually poor, since sustained changes in
PA may require much time and effort. In fact, both randomized controlled trials (RCTs) and
observational studies have shown that health benefits from PA/exercise may require large vol-
umes [20–22]. Nevertheless, in the long-term, even smaller volumes of daily PA may provide
beneficial effects on glycemic control [23] and mortality [5, 24, 25]. Increasing total daily
unstructured PA, mainly LPA, as suggested by current guidelines [13], may also reduce meta-
bolic and cardiovascular risk in patients with type 2 diabetes by decreasing the amount of
SED-time [14,15].
While the time spent in MVPA is usually low in subjects with type 2 diabetes, the level of
LPA and, conversely, the amount of SED-time may vary greatly, even in patients classified as
physically inactive and sedentary according to current definitions. However, both LPA and
SED-time are not accurately captured by questionnaires [26] and, hence, reliable data in
patients with type 2 diabetes are lacking. In subjects without diagnosed diabetes from the Aus-
Diab study, LPA was 5.8 hoursday-1, MVPA was 36.0 minday-1, and SED-time was 8.4
hoursday-1, on average, as measured objectively by accelerometer [27].
This study aimed at assessing the level and correlates of LPA, MVPA, and SED-time in
physically inactive and sedentary patients with type 2 diabetes participating in the Italian Dia-
betes and Exercise Study_2 (IDES_2).
Subjects and methods
In this cross-sectional analysis, we used the data collected at the baseline visit for the IDES_2.
This is an open-label, parallel RCT aimed at assessing the efficacy of a behavioral intervention
strategy, as compared with standard medical care, in increasing total daily PA and reducing
SED-time (primary endpoint) in patients with type 2 diabetes, as previously detailed [28].
Ethics
The study complies with the Declaration of Helsinki.
The research protocol, which follows the SPIRIT guideline, was approved by the Ethics
Committee of Sant’Andrea Hospital (Prot. n. 212/2012) and written informed consent was
provided by each participant.
Participants
The main entry criterion was known type 2 diabetes of at least 1-year duration. Additional
requirements were age 40–80 years, BMI 27–40 kg/m2, physical inactivity (i.e. less than 150
minweek-1 of moderate to vigorous aerobic exercise spread out over at least 3 days during the
week, with no more than 2 consecutive days between bouts of aerobic activity) [29], and seden-
tary lifestyle (i.e. more than 8 hoursday-1 spent in any waking behavior characterized by an
energy expenditure1.5 metabolic equivalents [METs]) [30] from at least 6 months, ability to
walk 1.6 Km without assistance, and eligibility after cardiologic evaluation.
The study was conducted in three tertiary referral outpatients Diabetes Clinics in Rome.
From October 2012 to February 2014, three-hundred patients were recruited to be randomized
1:1 to an intervention (INT) group (n = 150), receiving theoretical [21] and practical [31]
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exercise counseling on top of standard care, and a control (CON) group (n = 150), receiving
only standard care including general physician recommendations for daily PA [28].
Measurements
At baseline, all patients were asked to wear an accelerometer for objectively assessing PA and
SED-time. They also underwent assessment of physical fitness and measurement of anthropo-
metrical, clinical and biochemical parameters. Data on socio-demographic characteristics of
study subjects and presence of complications were also collected.
Assessment of PA and SED-time. At screening, PA level was evaluated retrospectively
using the Minnesota LTPA questionnaire [28]. Each participant was then outfitted with a uni-
axial piezoelectric accelerometer MyWellness Key (Technogym, Cesena, IT) [32], which offers
the possibilities of storing 30 days of continuous movement detection and provides measures
of the minutes spent at light, moderate and vigorous intensities and the total volume of PA,
which are aligned with other laboratory validations [33, 34]. This device was recently shown to
measure PA volume accurately and to acceptably discriminate between LPA and moderate
intensity PA in individuals with type 2 diabetes [35]. Each participant wore the device for
seven consecutive days. Upon waking, immediately after bathing or showering, participants
were asked to attach the device at the waistband in midline of the right anterior hip and to
wear it all day (except if swimming) up to bedtime. Patients were also asked to report on a
daily diary the hours spent wearing the instrument, sleeping and snapping, and performing
non-accelerometer recordable PAs such as swimming, cycling, skiing, etc.
The time the patient was awake and was not wearing the accelerometer was assumed to be
spent in sedentary activities (e.g. taking a shower, getting dressed), unless the participant
reported in the diary PAs which cannot be performed while wearing the accelerometer (e.g.
swimming). SED-time was then calculated by adding this time to that recorded by the acceler-
ometer with readings <100 countsmin-1, a threshold which corresponds with sitting, reclin-
ing, or lying down, i.e. to<1.5 METS [28].
Matthews’ cut-points were used to identify time spent in LPA (100–1951 countsmin-1 cor-
responding to 1.5–2.9 METs), whereas Freedson’s cut-points were used to determine time
spent in moderate intensity (1952–5724 countsmin-1 corresponding to 3–5.9 METs) and vig-
orous intensity (>5725 countsmin-1 corresponding to>6 METs) PA. Time spent in non-
accelerometer recordable PAs, as reported on the daily diary, was added to that recorded by
the accelerometer. Moderate intensity PA was combined with vigorous intensity PA into
MVPAs, as participants spent little time in vigorous intensity PA [28].
Assessment of physical fitness. Physical fitness was assessed by evaluating cardio-respira-
tory fitness, strength, and flexibility. The tests were preceded by two consecutive run-in ses-
sions to become familiar with testing devices and protocols.
Cardio-respiratory fitness was assessed by a maximal treadmill exercise test using a Balke
protocol and expressed as maximal oxygen uptake (VO2max), as previously detailed [28]. Iso-
metric muscle strength was measured by means of a strain gauge tensiometer (Digimax,
Mechatronic GmbH, Germany) [36]. Lower limb muscle strength was assessed by maximal
voluntary contractions (MVCs) performed at a costumed leg extension machine (Leg press,
Easy Line, Technogym), with a 90˚ angle at the knee and the hip. Upper body muscle strength
was assessed by MVCs performed at a shoulder press (Shoulder press/Lat pull, Easy Line,
Technogym) along the sagittal plane, with a 90˚ and 45˚ angle at the elbow and between the
upper arm and the trunk, respectively. For each exercise, three MVC were performed, with 3
min rest interval between contractions. For hip and trunk flexibility assessment, a standard
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bending test in the standing position was executed [28]. The test was performed three times
and the distance between the finger and the ground was measured at the third attempt.
Assessment of cardiovascular risk factors and scores. All patients underwent a struc-
tured interview in order to collect the following information: age, smoking status, known dia-
betes onset and duration, history of cardiovascular disease and microvascular complications,
current treatments including glucose-, BP- and lipid-lowering drugs.
Body weight and height were measured using scale and stadiometer and BMI was then cal-
culated as weight (kg)height-2 (m-2), while waist circumference was taken at the umbilicus.
Body composition was evaluated by assessing fat mass and fat-free mass by the use of a bio-
impedance device (Tanita BF664, Vernon Hills, IL, USA). Then, BP was recorded with a
sphygmomanometer after a five-minute rest with the patient seated with the arm at the heart
level.
Biochemical tests were centralized at the Laboratory of Clinical Chemistry of Sant’Andrea
Hospital, an accredited and ISO9001 certified structure. The following parameters were
assessed using standard analytical techniques [28]: HbA1c, fasting plasma glucose (FPG),
serum insulin, triglycerides, total, LDL and HDL cholesterol, high sensitivity-C-reactive pro-
tein (hs-CRP), serum creatinine, and albumin:creatinine ratio (ACR) on first-voided urine
samples. Then, the Homeostasis Model Assessment-Insulin Resistance (HOMA-IR) index was
calculated from FPG and insulin levels; estimated glomerular filtration rate (eGFR) was com-
puted from serum creatinine by the use of the Chronic Kidney Disease Epidemiology Collabo-
ration equation; and global and fatal coronary heart disease (CHD) and stroke 10-year risk
scores were calculated using the United Kingdom Prospective Diabetes Study (UKPDS) risk
engine, as previously detailed [28].
Statistical analysis
For the purpose of this analysis considering only baseline data, patients subsequently assigned
to the INT and CON groups were pooled together. Data are expressed as mean ± SD or num-
ber of cases (percentage). The χ2 test for categorical variables and the Student’s t test or the cor-
responding nonparametric Mann-Whitney test for continuous variables were utilized to
compare clinical characteristics between males and females. One-way ANOVA or the corre-
sponding nonparametric Kruskal-Wallis test were used to evaluate changes of measured vari-
ables with tertiles of LPA, MPVA, and SED-time.
Bivariate analyses of correlations between LPA; MVPA, or SED-time and physical fitness
parameters and cardiovascular risk factors and scores were performed using Spearman’s rho.
Partial correlation was also applied for adjusting each bivariate correlation for confounders.
Then, multivariate regression analyses with stepwise backward selection of variables were
applied to assess the independent correlates of LPA, MVPA, or SED-time. Covariates were
age, gender, diabetes duration, HbA1c, HOMA-IR, BMI, fat mass, waist circumference, systolic
BP, hs-CRP, eGFR, and ACR. Additional regression models were applied by including socio-
demographic features or presence of long-term complications.
Statistical analyses were performed at the CORE using SAS software release 9.3 (Cary, NC,
USA).
Results
Clinical characteristics of study subjects
Patients from the IDES_2 cohort had a mean age of 61.6 years (SD 9.9), a mean diabetes dura-
tion of 10.5 years (SD 8.0), and a male-to-female ratio of 61/39. The clinical features of study
subjects are reported in Table 1.
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On average, they showed a reasonably good, though not optimal, control of glucose
levels (mean HbA1c 7.38%) as well as of the other cardiovascular risk factors, with the
possible exception of adiposity level and distribution, and a significant 10-year risk of
CHD (>20%).
Table 1. Clinical features, physical fitness parameters, and PA and SED-time values in the whole cohort and by gender.
Variable Total Males Females P
n (%) 300 (100) 184 (61.3) 116 (38.7)
Age, years 61.6±9.9 61.0±9.8 62.6±10.0 0.163
Smoking, n (%) <0.0001
Never 122 (40.7) 41 (22.3) 81 (69.8)
Former 121 (40.3) 101 (54.9) 20 (17.2)
Current 57 (19.0) 42 (22.8) 15 (12.9)
Diabetes duration, years 10.5±8.0 10.5±8.3 10.6±7.7 0.711
HbA1c, % (nmolmol-1) 7.38±1.49 7.33±1.41 7.45±1.61 0.518
(57.1±16.3) (56.6±15.4) (57.9±17.6)
FPG, mmoll-1 7.56±2.73 7.47±2.48 7.70±3.09 0.969
Insulin, pmoll-1 89.3±86.2 86.7±91.3 93.4±77.6 0.280
HOMA-IR 4.48±5.60 4.44±6.41 4.54±4.00 0.292
BMI, kgm-2 30.0±5.1 29.1±4.5 31.4±5.6 <0.0001
Fat mass, % 31.7±10.2 25.8±7.6 40.9±6.0 <0.0001
Fat-free mass, kg 56.5±11.3 63.1±8.2 45.9±6.6 <0.0001
Waist circumference, cm 103.6±12.8 103.1±12.5 104.5±13.2 0.375
Triglycerides, mmoll-1 1.82±1.39 1.79±1.61 1.87±0.94 0.049
Total cholesterol, mmoll-1 4.67±1.01 4.55±0.98 4.86±1.02 0.009
HDL cholesterol, mmoll-1 1.22±0.36 1.15±0.34 1.34±0.36 <0.0001
LDL cholesterol, mmoll-1 2.89±0.87 2.90±0.92 2.89±0.77 0.931
Systolic BP, mmHg 140.1±20.4 138.9±18.6 142.0±23.0 0.193
Diastolic BP, mmHg 82.9±11.7 83.0±11.3 82.7±12.3 0.859
hs-CRP, mgl-1 4.99±8.82 3.59±4.37 7.21±12.79 0.004
eGFR, mlmin-11.73 m-2 87.1±18.4 87.7±18.1 86.2±19.0 0.509
ACR, mgg-1 73.4±332.7 84.3±401.0 56.2±177.4 0.132
UKPDS CHD 10-year risk score 20.6±13.8 24.7±14.8 14.3±9.0 <0.0001
UKPDS fatal CHD 10-year risk score 15.1±12.8 17.8±14.1 10.7±8.8 <0.0001
UKPDS stroke 10-year risk score 13.4±12.7 14.7±14.0 11.2±9.8 0.086
UKPDS fatal stroke 10-year risk score 2.18±2.44 2.33±2.58 1.94±2.18 0.211
VO2max, mlmin-1kg-1 24.7±6.5 26.8±5.9 21.2±5.7 <0.0001
Upper body strength, Nm 254.8±92.5 299.4±80.3 184.1±61.6 <0.0001
Lower body strength, Nm 161.1±60.4 188.8±53.9 117.3±41.1 <0.0001
Bending, cm 16.7±11.7 18.1±11.0 14.5±12.4 0.008
LPA, hoursday-1 3.93±1.35 4.20±1.36 3.50±1.24 <0.0001
MVPA, minday-1 12.4±4.6 13.8±4.2 10.1±4.4 <0.0001
SED-time, hoursday-1 11.6±1.2 11.4±1.2 11.9±1.2 <0.0001
Values are mean±SD for continuous variables and n (%) for categorical variables.
PA = physical activity; SED-time = sedentary time; FPG = fasting plasma glucose; HOMA-IR = Homeostasis Model Assessment-Insulin Resistance;
BP = blood pressure; hs-CRP = high sensitivity-C-reactive protein; eGFR = estimated glomerular filtration rate; ACR = albumin:creatinine ratio;
UKPDS = United Kingdom Prospective Diabetes Study; CHD = coronary heart disease; VO2max = maximal oxygen uptake; LPA = light intensity PA;
MVPA = moderate-to-vigorous intensity PA.
https://doi.org/10.1371/journal.pone.0173337.t001
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As previously reported [37], the cardiovascular risk profile was worse in females than in
males, though the UKPDS CHD risk scores remained higher in men. Medication use is
reported in S1 Table and was similar between males and females for most agents.
Level of PA and SED-time
As expected, physical fitness parameters indicated a low fitness and accelerometer measures
showed a low amount of both LPA (mean value 3.93 hoursday-1) and MVPA (mean value
12.4 minday-1) and a high level of SED-time (mean value 11.6 hoursday-1) (Table 1).
However, even if per protocol all patients were physically inactive and sedentary, the range
of LPA (0.89–7.11 hoursday-1), MVPA (0.6–21.0 minday-1), and SED-time (9.14–15.28
hoursday-1) values were quite wide (Fig 1).
Correlates of PA and SED-time
Bivariate correlations (Table 2) showed negative associations of both LPA and MVPA with
age, diabetes duration, HbA1c, FPG, HOMA-IR, BMI, fat mass, waist circumference, hs-CRP,
UKPDS risk scores, VO2max, strength, and SED-time. Only LPA correlated with ACR and
bending, whereas only MVPA correlated with fat-free mass, triglycerides, systolic blood pres-
sure, and eGFR. In contrast, SED-time was positively associated with age, diabetes duration,
HbA1c, FPG, insulin, HOMA-IR, BMI, fat mass, waist circumference, triglycerides, systolic
BP, hs-CRP, ACR, UKPDS risk scores, and physical fitness measures. When partial correlation
analysis was applied to adjust for confounders, only age, HbA1c, BMI or fat mass, and hs-CRP
remained significantly associated with LPA, MVPA and SED-time.
Levels of HbA1c, FPG, HOMA-IR, BMI, fat mass, waist circumference, hs-CRP, ACR,
UKPDS risk scores, and physical fitness parameters significantly improved with tertiles of LPA
and worsened with tertiles of SED-time (except for ACR). A trend similar to that of LPA was
observed with tertiles of MVPA, except for a significant decrease of systolic blood pressure,
but not of FPG, ACR, total CHD risk score, and bending, and an increase in fat-free mass
(Table 3).
At multivariate analysis, age, female gender, HbA1c, BMI (for LPA) or waist circumference
(for MVPA and SED-time), and hs-CRP (for LPA and SED-time only) were negatively associ-
ated with LPA and MPA and positively associated with SED-time in an independent manner
(Table 4). The total fraction of variance in LPA, MPA, and SED-time accounted for by vari-
ables included in multiple regression models were 22.7%, 28.4%, and 21.0%, respectively.
Results did not change when socio-demographic characteristics or presence of complications
were included in the models. These variables were not or minimally associated with LPA,
MPA, and SED-time when analyzed in regression models including only age and gender (not
shown).
Discussion
This work provides, for the first time, an objective picture of the level of PA and sedentary
behavior in patients with type 2 diabetes willing to participate in a research-based PA trial and
identifies the main correlates of LPA, MVPA, and SED-time in these individuals.
Level of PA and SED-time
The main findings of this study are the low level of PA / high level of sedentary behavior in
patients with type 2 diabetes and the large variability of accelerometer measures in individuals
who are classified as physically inactive and sedentary according to current definitions. In fact,
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on average, study subjects showed accelerometer-derived measures of LPA, MVPA, and SED-
time which were worse than those observed in nondiabetic individuals from the AusDiab [27].
Moreover, half of participants in the IDES_2 fell in a range LPA (2.96–4.93 hoursday-1),
MVPA (9.0–16.0 minday-1), and SED-time (10.6–12.4 hoursday-1) far from the thresholds
indicated by current guidelines [13]. These observations indicate that there is a large room for
action in order to increase PA level and to decrease SED-time to the recommended levels in
patients with type 2 diabetes.
The very strong correlation between LPA and SED-time confirms the close inverse asso-
ciation between the two parameters and supports the recommendation to increase not only
Fig 1. Distribution of LVPA, MVPA, and SED-time values in the study subjects. Median (interquartile
range) for each variable are reported on the right. LPA = light intensity physical activity; MVPA = moderate-to-
vigorous intensity; SED-time = sedentary time.
https://doi.org/10.1371/journal.pone.0173337.g001
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MVPA, but also LPA, in order to contrast the independent deleterious effect of sedentary
behavior on health outcomes [13]. As suggested by others [14, 15], increasing LPA might
represent the first step toward the adoption of a physically active lifestyle, as it would reduce
SED-time and increase physical function, thus allowing patients to subsequently engage in
MVPA.
Some subjects were found to engage in virtually no PA and to spend almost all the time in a
sitting or reclining position, whereas some other individuals approached the recommended
levels. This finding suggests that prescription of PA/exercise to patients with type 2 diabetes
should be preceded by an accurate evaluation of behavior of each individual, with particular
Table 2. Bivariate correlations of LVPA, MVPA, and SED-time with cardiovascular risk factors and scores and physical fitness parameters (Spear-
man’s rho).
Variable LPA MVPA SED-time
R P R P R P
Age -0.198 0.001 -0.281 <0.0001 0.152 0.008
Diabetes duration -0.153 0.008 -0.178 0.002 0.167 0.004
HbA1c -0.305 <0.0001 -0.196 0.001 0.323 <0.0001
FPG -0.222 <0.0001 -0.144 0.012 0.218 <0.0001
Insulin -0.109 0.059 -0.100 0.084 0.139 0.016
HOMA-IR -0.180 0.002 -0.137 0.018 0.207 <0.0001
BMI -0.248 <0.0001 -0.218 <0.0001 0.225 <0.0001
Fat mass 0.243 <0.0001 -0.351 <0.0001 0.227 <0.0001
Fat-free mass 0.077 0.183 0.205 <0.0001 -0.071 0.224
Waist circumference -0.230 <0.0001 -0.214 <0.0001 0.200 <0.0001
Triglycerides -0.111 0.055 -0.127 0.027 0.135 0.019
Total cholesterol 0.031 0.596 0.074 0.199 -0.026 0.657
HDL cholesterol 0.048 0.403 0.021 0.717 -0.066 0.253
LDL cholesterol 0.069 0.233 0.136 0.018 -0.074 0.202
Systolic BP -0.089 0.124 -0.177 0.002 0.116 0.045
Diastolic BP -0.003 0.956 0.001 0.975 0.028 0.628
hs-CRP -0.226 <0.0001 -0.256 <0.0001 0.202 0.001
eGFR 0.093 0.110 0.136 0.018 -0.041 0.479
ACR -0.155 0.007 -0.035 0.547 0.136 0.018
UKPDS CHD risk score -0.162 0.005 -0.118 0.042 0.142 0.014
UKPDS fatal CHD risk score -0.206 <0.0001 -0.189 0.001 0.187 0.001
UKPDS stroke risk score -0.182 0.002 -0.239 <0.0001 0.148 0.010
UKPDS fatal stroke risk score -0187 0.001 -0.256 <0.0001 0.161 0.005
VO2max 0.586 <0.0001 0.663 <0.0001 -0.522 <0.0001
Upper body strength 0.281 <0.0001 0.397 <0.0001 -0.235 <0.0001
Lower body strength 0.341 <0.0001 0.412 <0.0001 -0.299 <0.0001
Bending -0.143 0.013 -0.107 0.064 0.142 0.014
LPA - - 0.591 <0.0001 -0.855 <0.0001
MVPA 0.591 <0.0001 - - -0.547 <0.0001
SED-time -0.855 <0.0001 -0.547 <0.0001 - -
LPA = light intensity physical activity; MVPA = moderate-to-vigorous intensity; SED-time = sedentary time; FPG = fasting plasma glucose;
HOMA-IR = Homeostasis Model Assessment-Insulin Resistance; BP = blood pressure; hs-CRP = high sensitivity-C-reactive protein; eGFR = estimated
glomerular filtration rate; ACR = albumin:creatinine ratio; UKPDS = United Kingdom Prospective Diabetes Study; CHD = coronary heart disease; VO2max =
maximal oxygen uptake.
https://doi.org/10.1371/journal.pone.0173337.t002
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reference to the amount of daily unstructured PAs and time spent in sitting or reclining posi-
tion, in order to provide patients with adequate and specific recommendations.
Correlates of PA and SED-time
The close associations of accelerometer measures with virtually all metabolic parameters and
cardiovascular risk factors and scores support the importance of increasing LPA (and MVPA)
and concurrently decreasing SED-time. In particular, this analysis highlights the link between
PA behavior and glycemic control, adiposity and inflammation, with HbA1c, BMI or waist cir-
cumference, and hs-CRP correlating independently with LPA, MVPA, and SED-time, together
with age and gender. These observations are consistent with the recognized role of physically
inactivity and sedentary behavior in the ongoing epidemic of obesity and type 2 diabetes [1,2].
They are also in agreement with current guidelines considering PA/exercise as a cornerstone
in the prevention and management of type 2 diabetes [13] as well as with the anti-inflamma-
tory effect of PA/exercise [38], which was shown to reduce markers of inflammation and insu-
lin resistance, independent of weight loss [39].
More importantly, these data indicate that small improvements in LPA, MVPA, and SED-
time might be associated with better glycemic control and cardiovascular risk profile, even if
absolute values remain quite distant from recommended levels. In fact, values of LPA, MVPA,
and SED-time falling in the best tertile (i.e. >4.57 hoursday-1, >15.0 minday-1, and<10.86
hoursday-1, respectively) were shown to be associated with optimal or acceptable levels of
metabolic parameters and cardiovascular risk factors and scores, whereas the opposite was
observed for values in the worst tertiles. These findings support the concept that even limited
behavioral changes with small volumes of daily PA, mainly of low intensity, may provide bene-
ficial effects in patients with type 2 diabetes [5, 23–25], thus suggesting the need to encourage
all patients to be more active, while setting more or less ambitious goals based on the individ-
ual attitude and compliance. However, due to the cross-sectional nature of this analysis, this
hypothesis needs to be confirmed by intervention studies, such as the IDES_2. In fact, a poor
cardiovascular risk profile might be the cause, rather than the effect, of physical inactivity and/
or sedentary behavior, though the beneficial impact of increasing PA and reducing sedentary
SED-time on glycemic control and modifiable cardiovascular risk factors is well-established.
Strengths and limitations
A major strength of our study is that this is the first report on objective measures of PA and
SED-time in a large contemporary cohort of patients with type 2 diabetes, very well character-
ized for cardio-metabolic risk profile and physical fitness level.
Table 4. Independent correlates of PA and SED-time (multiple regression analysis with stepwise backward selection of variables).
Variable LPA MVPA SED-time
Beta P Beta P Beta P
Age -0.175 0.001 -0.262 <0.0001 0.144 0.006
Female gender -0.323 0.001 -0.332 <0.0001 0.137 0.011
HbA1c -0.246 <0.0001 -0.165 0.001 0.310 <0.0001
BMI -0.326 0.001 - - - -
Waist circumference - - -0.155 0.002 0.122 0.022
hs-CRP -0.135 0.013 - - 0.177 0.001
PA = physical activity; SED-time = sedentary time; LPA = light intensity PA; MVPA = moderate-to-vigorous intensity PA; hs-CRP = high sensitivity-C-
reactive protein.
https://doi.org/10.1371/journal.pone.0173337.t004
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One limitation is the cross-sectional design, which does not allow assessing cause-effect
relationships. Finally, the IDES_2 cohort is not fully representative of patients with type 2 dia-
betes, as subjects having any condition limiting/contraindicating PA or achieving the recom-
mended level of PA were excluded. However, this analysis was specifically aimed at assessing
the PA and SED-time profile of physically inactive and sedentary patients with type 2 diabetes,
who represent the vast majority of the individuals suffering from this condition and those who
are candidate to receive (and may benefit from) a behavioral intervention for adopting a physi-
cally active lifestyle.
Conclusions
In conclusion, the objective assessment of PA behavior by accelerometer in physically inactive
and sedentary patients with type 2 diabetes from the IDES_2 showed that level of PA is low in
these individuals, though values of LPA, MVPA, and SED-time vary largely.
Furthermore, there is a strong correlation between these measures and cardio-metabolic
risk profile, with an independent association with HbA1c, BMI or waist circumference, and hs-
CRP, in addition to age and gender.
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